A B S T R A C T The mechanism of renal potassium wasting in renal tubular acidosis associated with the Fanconi syndrome (type 2 RTA) was investigated in 10 patients, each of whom had impaired proximal renal tubular reabsorption of bicarbonate as judged from a greater than 15-20% reduction of renal tubular bicarbonate reabsorption (THCO3-) at normal plasma bicarbonate concentrations. When the plasma bicarbonate concentration ([HCOs-]p) was experimentally increased to normal levels in three patients with a fractional potassium excretion (CK/Cin) of less than 1.0 during acidosis, CK/Ci. and urinary potassium excretion (UKV/CIU) increased strikingly and concurrently with a striking increase in urinary sodium (UNaV/Cin) and bicarbonate (UHcos-V/Cin) excretion. When [HCOs-]p was increased to normal levels in two patients with a CK/Cin of greater than 1.0 during acidosis and in whom UNaV/Cln and UHCOI-V/CIU were already markedly increased, CK/CIn did not increase further. When [HCOi-]p was decreased to subnormal levels in a patient given ammonium chloride, UKV/CGI, CK/CIn, and UHCO3-V/CIn decreased concurrently. In the six patients in whom [HCOj-]p was maintained at normal levels (oral alkali therapy) for 2 months or longer, CK/Cin was directly related to the urinary excretion rates of sodium and bicarbonate, hence was directly related to the magnitude of reduction of THCOi-at normal [HCOs-] either increased from subnormal to normal levels, or decreased from normal to subnormal levels, U1co,-V/Ci. remained essentially constant, and UKV/Cin did not change significantly. When correction of acidosis was sustained, UIJcOs-V/Cin remained a trivial fraction of that filtered, and CK/Cin was consistently less than 0.55.
INTRODUCTION
Renal potassium wasting' is a common complication of the clinical syndrome of renal tubular acidosis (RTA) (1) (2) (3) (4) (5) (6) (7) (8) . Both in patients with so-called classic RTA (type 1 RTA, "distal" or "gradient" RTA) and in patients with RTA associated with the Fanconi syndrome (type 2 RTA, "proximal" or "rate" RTA), it has been inferred that renal potassium wasting is a reversible consequence of the renal acidification defect (1, 4, 8, (9) (10) (11) (12) (13) . In patients with type 1 RTA, this infer-'Renal potassium wasting is defined as the continued urinary excretion of more than 40 mEq of potassium daily in the face of potassium depletion of severity sufficient to produce hypokalemia.
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ence is based on the observation that correction of systemic acidosis with alkali therapy can lead to a reduction in urinary potassium excretion and correction of hypokalemia (1, 2, 13) . In patients with type 2 RTA, this response to corrective alkali therapy has been assumed (12) but apparently never documented (3, 5, 6) .
In patients with type 2 RTA, however, the physiologic character of the underlying renal acidification defect suggests the possibility that renal potassium wasting might be augmented rather than corrected by correction of systemic acidosis (14) . In these patients, the renal acidification defect is characterized by complete, or nearly complete, renal tubular reabsorption of bicarbonate at subnormal plasma bicarbonate concentrations but by a greater than 15-20% reduction in tubular reabsorption of bicarbonate at normal plasma bicarbonate concentrations, a finding indicating that the rate of bicarbonate reabsorption in the proximal nephron is reduced (15, 16) . Accordingly, raising the plasma bicarbonate concentration from subnormal to normal levels has the immediate and sustained effect of swamping the distal nephron with massive amounts of NaHCO3. In the presence of a continued stimulus for sodium reabsorption, the delivery to the distal nephron of such supernormal amounts of NaHCO3 might be expected to increase intraluminal negativity, augment potassium secretion, and thereby promote renal potassium wasting (17) (18) (19) (20) .
To investigate this possibility and to compare the effects of correction of acidosis on renal potassium wasting in patients. with type 1 and 2 RTA, we measured urinary potassium excretion and fractional potassium excretion in the two groups (a) at plasma bicarbonate concentrations progressively increased from subnormal to normal levels by intravenous administration of NaHCO3 and (b) at normal plasma bicarbonate concentrations sustained for 2 months or longer. The results of these investigations indicate that in type 2 RTA, the physiologic character of renal potassium wasting is distinct from that in type 1 RTA and support the hypothesis that in type 2 RTA renal potassium wasting results in part from the delivery of supernormal amounts of NaHCO3 to the distal nephron.
METHODS
A total of 29 clearance studies were carried out on the following 23 subjects: 8 patients with type 1 RTA; 10 patients with type 2 RTA; and 5 normal subjects.
All studies were performed in the early morning with the patients lying comfortably supine. Breakfast was withheld but free access to water was permitted before and during the studies. Spontaneously voided urine (men, boys) or urine from an indwelling Foley catheter (women, infants) was collected under a layer of mineral oil at 15-to 30-min intervals for immediate determination of pH and carbon dioxide content and for subsequent determination of sodium, potassium, and chloride. At appropriate intervals arterialized blood was drawn from a superficial vein on the back of the hand that had been heated with an electric heating muffler to at least 450C for more than 60 min for determination of blood pH and carbon dioxide tension and serum sodium and potassium concentrations. Inulin clearance was measured throughout each study period.
NaHCOs infusion. 10 studies were designed to examine the effect on urinary potassium excretion (UKV/Cin) and fractional potassium excretion (CK/C In) of progressively increasing the plasma bicarbonate concentration from subnormal to normal levels by intravenous infusion of sodium bicarbonate. The subj ects were five patients with type 2 RTA (R. A., R. G., R. Y., G. F., A. M.) and four patients with type 1 RTA (C. V., Le. S., La. S., P. B.) (Table I) . When studied, each patient had been in a spontaneous state of mild or moderate systemic acidosis for at least 3 days. In each study plasma bicarbonate was increased by approximately 2 mmoles/liter per hr by the intravenous administration of a 3.75%o solution of sodium bicarbonate at rates ranging from 0.25 to 3.8 ml/min. In most studies the rate of infusion remained constant throughout; in some studies on the patients with type 2 RTA, it was necessary to increase the rate of infusion at the higher plasma bicarbonate concentrations.
Sustained correction of acidosis. 17 studies were designed to compare fractional potassium excretion in type 1 and type 2 RTA during prolonged correction of systemic acidosis. The subjects were six patients with type 2 RTA (R. G., M. P., M. H., M. N., E. S., B. L.), six patients with type 1 RTA (C. V., Le. S., B. Mc., N. A., K. E., L. C. S.) (Table I) , and five normal subjects ranging in age from 27 to 46 yr. For at least 2 months immediately preceding the studies, normal plasma bicarbonate concentrations (22-26 mmoles/liter) had been maintained in each patient by appropriate alkali therapy (Table I) . Two to six consecutive 15-to 30-min urine collections were obtained for determination of fractional potassium excretion. In some studies, urine collections were obtained over a narrow range of normal plasma bicarbonate concentrations (1-3 mmoles/liter) achieved by intravenous infusion of small amounts of sodium bicarbonate.
NH4Cl loading. In a patient with type 2 RTA (R. A.) and in a patient with type 1 RTA (L. C. S.), paired studies were performed to compare the effect on UKV/Cin and CK/CIn of progressively decreasing the plasma bicarbonate concentration from normal to subnormal levels. The plasma bicarbonate concentration was decreased by oral administration of ammonium chloride; after an initial dose of 6 g (R. A.) or 2 g (L. C. S.), each patient received 5 g in divided doses over the subsequent 2 hr.
Laboratory methods. Laboratory determinations were carried out as described previously (15, 21) . Sustained correction of acidosis. In six patients with type 2 RTA studied after prolonged correction of systemic acidosis, fractional potassium excretion varied from 0.53 to 3.47 at serum potassium concentrations ranging from 2.5 to 4.5 mEq/liter (Fig. 3) . In two patients (M. N., M. P.), CK/Cin was less than 1.0; and in four patients (R. G., E. S., M. H., B. L.), CK/Cin was consistently greater than 1.0 at plasma bicarbonate concentrations ranging from 22 to 26 mmoles/liter. The values of CK/Cin varied directly and nearly linearly with the urinary excretion rates of bicarbonate ( Fig. 3) and sodium. In general, CK/Cin varied inversely with the glomerular filtration rate (GFR) (Fig. 4) . While a similar inverse relationship between CK/Cin and GFR occurs in chronic renal disease of diverse etiology, the values of CK/Cin in the patients with type 2 RTA were, in comparison, consistently higher at any given GFR (Fig. 4) (27) . That the disproportionately greater fractional potassium excretion reflects in fact "renal potassium wasting" in the patients with type 2 RTA is indicated by the presence of frank hypokalemia (2.5 < K. < 3.8) in four of the patients (M. P., M. N., R. G., E. S.) despite the provision of potassium supplements as well as a normal dietary potassium intake. In unpublished balance studies on three of these patients (M. P., R. G., E. S.), the total daily potassium requirement necessary to maintain serum potassium concentratrons in the low-normal range exceeded 2 mEq/Kg, even though glomerular filtration rate was reduced.
RESULTS
In the six patients with type 1 RTA studied after prolonged correction of acidosis, fractional potassium excretion varied from 0.17 to 0.39 at serum potassium concentrations ranging from 3.5 to 4.2 mEq/liter ( NH4Cl loading studies. When the plasma bicarbonate concentration was progressively decreased from 22.8 to 12.9 mmoles/liter in a patient with type 2 RTA (R. A.), UKV/Cin and CK/Cin decreased progressively from 3.46 to 1.75 /Eq/ml and 0.82 to 0.42, respectively, concomitant with a progressive decrease in UHCo3-V/Cin from 4.59 to 0.68 imoles/ml and an increase in urinary chloride excretion (Uc1V/CI.) from 1.56 to 3.10 AEq/ml (Table IV) . The greatest reduction in UKV/Cin, CK/Cln, and UHco3-V/Ct. occurred as the plasma bicarbonate concentration decreased to 16.6 mmoles/liter. In contrast, when the plasma bicarbonate concentration was progressively decreased from 22.8 to 16.7 mmoles/liter in a patient with type 1 RTA (L. C. S.), UKV/Cin, CK/Cin, UHCo3-V/Cin, and UCI-V/Cin remained essentially constant (Table IV) . No significant change in urinary sodium excretion occurred in either study.
Urinary aldosterone. (22) . Normal values for adults were established in a previous study (23) ; normal values for children and infants, corrected to 1.73 mi, were derived by measurements (a) on the last day of a 3-5 day period of NH4Cl-induced acidosis in children aged 1-16 yr (24) . and (b) after a single oral dose of NH4Cl (75 mEq/m2) in children aged 4-13 yr (25) (16, 28) , the syndrome of renal tubular acidosis can reflect two physiologically distinct disorders of renal acidification. In patients with so-called classic RTA (type 1 RTA, "distal" or "gradient" RTA), the urinary pH remains inappropriately high during mild as well as severe degrees of acidosis and persisting bicarbonaturia is characteristic. The amount of bicarbonate excreted, however, remains a trivial fraction of that filtered both at subnormal and at normal plasma bicarbonate concentrations, a finding which indicates no substantial reduction in the rate at which the proximal (or distal) nephron reabsorbs bicarbonate (4, 9). In contrast, in patients with RTA associated with the Fanconi syndrome (type 2 RTA, "proximal" or "rate" RTA), the amount of bicarbonate excreted at normal plasma bicarbonate concentrations is more than 15% of that filtered, indicating that the rate of reabsorption of bicarbonate in the proximal nephron is reduced (15, 16) . Prototypically in patients with type 2 RTA, the urinary pH is inappropriately high, and bicarbonaturia occurs only during mild or moderate degrees of acidosis; during more severe degrees of acidosis, bicarbonaturia disappears and the urinary pH decreases to normal minima (15, 28, 29) .
The results of the present study provide evidence that renal potassium wasting in type 2 RTA is physiologically separable from that in type 1 RTA and in part the result of a reduction in the rate at which the proximal nephron reabsorbs bicarbonate and the consequent delivery to the distal nephron of supernormal amounts of NaHCOs. In each of the 10 patients studied with type 2 RTA, bicarbonate reabsorption in the proximal nephron was almost certainly impaired, since at normal plasma bicarbonate concentrations renal bicarbonate reabsorption was invariably reduced by more than 15% (Table I) . In four studies on three patients with type 2 RTA, urinary potassium excretion (UaV) and fractional potassium excretion (CK/Cin) increased strikingly when the plasma bicarbonate concentration was progressively increased from subnormal to normal or near normal levels by intravenous infusion of NaHCOs. As would have been predicted from the physiological character of the renal acidification defect in these patients, urinary sodium and bicarbonate excretion also increased strikingly and concomitantly. In the two patients in whom fractional potassium excretion did not increase when the plasma bicarbonate concentration was increased to normal levels, the base line values of fractional potassium excretion during acidosis were already considerably greater than the maximal values observed in the other three patients In the patient with type 2 RTA in whom the plasma bicarbonate concentration was decreased by the administration of ammonium chloride, the finding that urinary sodium excretion did not decrease as urinary potassium excretion decreased does not indicate that the initially high urinary excretion rates of potassium were not the result of increased distal delivery of NaHCOs. Since in this study the reduction in urinary excretion of bicarbonate was accompanied by an increase in urinary excretion of chloride, it can be inferred that the delivery of HC03-and Cl-to the distal nephron decreased and increased, respectively. For a given delivery of sodium to the distal nephron and a given stimulus for renal sodium reabsorption, the combination of an increased distal delivery of the highly permeant anion, chloride, and a 1.5 indicates that even complete suppression of potassium reabsorption in the proximal nephron would not have been sufficient to account for the degree of renal potassium wasting (18, 19) .
In the patients with type 1 RTA, delivery of super- normal amounts of NaHCOs to the distal nephron could not be supported as a cause of renal potassium wasting. In each of the eight patients studied, the rate of bicarbonate reabsorption in the proximal nephron could not have been substantially reduced since tubular reabsorption of bicarbonate at normal plasma bicarbonate concentrations was nearly complete (Table I ). In the four patients with type 1 RTA in whom the plasma bicarbonate concentration was progressively increased from subnormal to normal levels by intravenous infusion of NaHCOs, UKV and CK/Ciu remained essentially constant or decreased. As would have been predicted from the physiological character of the renal acidification defect in these patients, urinary bicarbonate excretion also remained essentially constant until normal or supernormal plasma bicarbonate concentrations were reached. In the one patient in whom the plasma bicarbonate concentration was rapidly decreased by the administration of ammonium chloride, UKV and CK/Ci. remained essentially constant, as did urinary sodium and bicarbonate excretion. In the six patients with type 1 RTA maintained at normal plasma bicarbonate concentrations for 2 months or longer, fractional potassium excretion was consistently less than 0.55 and did not correlate with the urinary excretion rates of either sodium or bicarbonate.
In patients with type 2 RTA but not in patients with type 1 RTA, the results of the present studies permit the prediction that renal potassium wasting will occur invariably and even worsen when systemic acidosis is corrected with alkali therapy. Conceivably, during pro- 
